Stocktoria
ABBOTT LABORATORIES ABT
NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 1937-03-01
ABBOTT LABORATORIES statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | 18.2% | 16.3% | 16.2% | 19.2% | 19.6% |
| Net margin | 14.7% | 31.9% | 14.3% | 15.9% | 16.4% |
| FCF margin | 16.7% | 15.1% | 12.6% | 17.9% | 20.1% |
| Return on assets | 7.5% | 16.5% | 7.8% | 9.3% | 9.4% |
| Return on equity | 12.4% | 28.0% | 14.7% | 18.8% | 19.6% |
| Debt / equity | 0.25× | 0.29× | 0.38× | 0.45× | 0.50× |
| Current ratio | 1.58 | 1.67 | 1.64 | 1.63 | 1.85 |
| Revenue growth | 5.7% | 4.6% | -8.1% | 1.3% | 24.5% |
Source: SEC EDGAR filings · CIK 0000001800 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.